Breast cancer

Breast cancer

One in 8 women in the EU will develop breast cancer before the age of 85. This disease is associated with a great economic cost. In fact, in 2010 it was estimated at more than €15 billion in Europe. About 46% of the breast cancer cost is spent on treatments and drugs1 that are selected by general guidelines and may not be efficient for a specific patient.

1 in 8

women will develope it


>€ 15 billion cost

Drugs selected by general


Led by IBM, this pilot supports precision medicine to improve accuracy in diagnosis and propose treatments that are more targeted, less toxic and therefore better tolerated.

Why a big data approach is needed

Prediction by big data analytics can support the physicians on their decision for the personalized optimal treatment for the patient.
Institut Curie


Pillot 8: Breast cancer


Poster at the BigMedilytics event: “Big Data: Fueling the transformation of Europe’s Healthcare Sector”. September 4-5, 2019, Valencia, Spain

1 Source: Capri S., Russo A.: Cost of breast cancer based on real-world data: a cancer registry study in Italy, BMC health Services Research, 17(1):84, 2017.